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Abstract
The Kallikrein-Kinin System (KKS) has been implicated in several aspects of metabolism, including the regulation of glucose
homeostasis and adiposity. Kinins and des-Arg-kinins are the major effectors of this system and promote their effects by
binding to two different receptors, the kinin B2 and B1 receptors, respectively. To understand the influence of the KKS on
the pathophysiology of obesity and type 2 diabetes (T2DM), we generated an animal model deficient for both kinin receptor
genes and leptin (obB1B2KO). Six-month-old obB1B2KO mice showed increased blood glucose levels. Isolated islets of the
transgenic animals were more responsive to glucose stimulation releasing greater amounts of insulin, mainly in 3-month-old
mice, which was corroborated by elevated serum C-peptide concentrations. Furthermore, they presented hepatomegaly,
pronounced steatosis, and increased levels of circulating transaminases. This mouse also demonstrated exacerbated
gluconeogenesis during the pyruvate challenge test. The hepatic abnormalities were accompanied by changes in the gene
expression of factors linked to glucose and lipid metabolisms in the liver. Thus, we conclude that kinin receptors are
important for modulation of insulin secretion and for the preservation of normal glucose levels and hepatic functions in
obese mice, suggesting a protective role of the KKS regarding complications associated with obesity and T2DM.
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Introduction
Obesity and type 2 diabetes mellitus (T2DM) are important
public health problems in several countries [1]. Both conditions
are associated and the risk for T2DM can increase by about 300%
in obese subjects [2], while weight gain seems often to precede the
development of T2DM. Therefore, the higher incidence of obesity
in several populations in the last three decades has been
accompanied by an increase in T2DM [3].
T2DM involves changes in carbohydrate, lipid and protein
metabolisms and is directly linked with insulin resistance and the
inability of pancreatic beta cells to compensate this phenomenon
[4]. The importance of the liver in the pathophysiology of T2DM
is also widely recognized. The liver is the main organ responsible
for endogenous glucose production, and increased hepatic glucose
production is the major cause of hyperglycemia in poorly
controlled T2DM patients [5]. Additionally, it has been shown
in obese subjects that fatty livers increase insulin resistance and
promote T2DM [6].
Non-alcoholic fatty liver disease (NAFLD) is a term used to
describe a wide spectrum of liver damages, ranging from simple
steatosis to steatohepatitis and cirrhosis. NAFLD is associated with
obesity and insulin resistance [7]. Non-alcoholic steatohepatitis
(NASH), a subtype of NAFLD characterized by hepatocyte injury
and inflammation leading to increased risk of cirrhosis develop-
ment, is present in 10% of patients with T2DM [8].
Kinins are vasoactive peptides locally produced in the
circulatory system and other tissues by the action of serine
proteases called kallikreins. Bradykinin (BK) and des-Arg9-
bradykinin (Des-Arg-BK) are the main effectors of the KKS in
rodents. These peptides bind to the B2 and B1 kinin receptor,
respectively [9], leading to the sensation of pain, vasodilatation,
vascular permeability, inflammation and oedema formation [10].
These receptors have also been linked to the pathophysiology of
diabetes [11,12]. BK increases glucose uptake in muscle and
adipose tissue [13] while the BK metabolite Des-Arg-BK has been
shown to control leptin sensitivity in the hypothalamus [14] and
insulin release in pancreatic islets [15].
To study the involvement of the KKS in the pathophysiology of
T2DM in the context of obesity, we generated genetically obese
mice (ob/ob) lacking both kinin B1 and B2 receptors. We were thus
able to show that complete abrogation of kinin function has
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dramatic consequences on metabolism, which includes exacerba-
tion of NAFLD and impairment of glucose homeostasis and
pancreatic function in obese mice.
Results
ObB1B2KO Mice Present Similar Body Mass and Body
Composition when Compared to obWT Controls
The most obvious characteristic of ob/ob (obWT) mice is the
severe obesity that these animals develop already at younger ages.
The additional absence of functional kinin B1 and B2 receptors
did not alter this condition (figure 1A and B). Analyzed by
densitometry, body composition did not show significant differ-
ences in the percentage of fat and lean mass (figure 1C and D). We
also analyzed the mass of some organs and tissues like the spleen,
kidneys, muscle triceps sural, heart and adipose tissue. The
obB1B2KO mice showed however no significant mass differences
of these tissues when compared to obWT mice (table S1).
ObB1B2KO Mice Exhibit Age-associated Hyperglycemia
and Insulin Resistance
It is known that obWT mice have improved glycemic values
when growing older than 20 weeks of age [16]. This characteristic
is obliterated in the obB1B2KO mice (figure 2). Three-month-old
animals exhibited similar glucose and insulin tolerance (figure 2A,
D and G). However, while 6-month-old obWT mice showed
improved glucose tolerance and decreased glucose levels in
comparison to their younger counterparts, 6-month-old
obB1B2KO mice displayed a further impairment in glucose
tolerance and a significant increase of fasting glycemia (Figure 2B
and C). This results in drastic differences in glucose homeostasis in
6-month-old obB1B2KO when compared with obWT (figure 2).
We also analyzed the insulin sensitivity in both ages (figure 2D to
I). The figures 2D to 2F show that 6-month-old obB1B2KO mice
present an increase of glycemia with higher area under the curve
and this effect is mainly due to the differences observed in basal
levels of fasting glucose. We also present the normalized data
(figure 2G and H) and estimated the constant rate for glucose
disappearance (KITT) shown in figure 2I. The KITT analysis shows
a reduction of insulin sensitivity in 6-month-old obB1B2KO mice
when compared with the other groups.
Three-month-old obB1B2KO Mice Presented Increased
Hepatic Insulin Resistance
After immunopreciptation, western blot analysis showed inhi-
bition of insulin receptor phosphorylation in the liver of
obB1B2KO mice (figure 3A) when compared with obWT mice.
On the other hand, the activation of the insulin receptor in the
muscle of obB1B2KO mice is similar in obese controls (figure 3B).
These results suggest the development of local insulin resistance
starting in the liver.
Figure 1. ObB1B2KO have similar body weight and body composition. A) Growth curve showing the body weight of mice from 6 to 24
weeks of age; B) Average body weight of 30-week-old mice; C and D) Densitometry of obWT and obB1B2KO at the age of 25 weeks. Data are
presented as means 6 SEM; n .9.
doi:10.1371/journal.pone.0040573.g001
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The Kallikrein-kinin System Modulates Insulin Secretion
of Pancreatic Islets
To assess how pancreatic islets could compensate for glucose
intolerance in obWT mice, pancreatic islets from 3- and 6-month-
old mice were isolated and incubated with different concentrations
of glucose. Islets obtained from 3-month-old obB1B2KO mice
secreted similar basal levels of insulin when compared to islets
from obWT mice, but reacted more potently to glucose (3- to 7-
fold, figure 4A and C). On the other hand, while glucose-
stimulated insulin secretion increased substantially with age in
islets of obWT mice, this increase was marginally observed in
obB1B2KO mice (figure 4B and D). We also estimated the EC50
(effective concentration) values. At 3 months of age the EC50
glucose values were 16.97+/20.352 mM and 11.30+/
20.196 mM for obWT and obB1B2KO respectively (average
+/2 SD). The EC50 values were reduced in both groups at 6
months of age and the difference between obWT and obB1B2KO
were significantly reduced: 8.41+/20.217 mM and 6.29+/
20.651 mM. To confirm these results, dynamic analysis of insulin
secretion was performed.
To this end, islets were placed in mini chambers and perifused
with Krebs solution containing different concentrations of glucose.
Young obB1B2KO mice islets showed a higher response to
glucose (figure 4E), which was not observed in older animals
(figure 4F). Although no significant differences in the amount of
secreted insulin during high glucose stimulation were observed in
islets from 6-month-old mice (figure 4F, H and J), obB1B2KO
islets needed a longer recovery time to establish basal insulin
secretion levels when glucose concentration in the medium was
lowered below 2.8 nM (figure 4F, I and K). Together these results
suggest that insulin resistance in ob/ob mice can be compensated
by increased insulin secretion, which is particularly observed in
aged mice when glucose tolerance improves while insulin secretion
increases. In mice lacking both kinin receptors, however, the
increased insulin secretion can no further compensate the
pronounced insulin resistance that accompanies aging in
obB1B2KO mice, leading to severe glucose intolerance.
Figure 2. Six-month-old obB1B2KO mice present higher glycemia and insulin resistance when compared to obWT. A to C) Glucose
tolerance test (GTT) of transgenic mice and controls; D to H) Absolute and relative values of the insulin tolerance test (ITT) of transgenic mice and
controls. I) The constant rate of glucose disappearance (Kitt) calculated from ‘‘G’’ and ‘‘H’’. Data are presented as means 6 SEM. Student’s t-test: *,
p,0.05; ***, p,0.001; n = 8.
doi:10.1371/journal.pone.0040573.g002
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Circulating C-peptide Levels are Elevated in obB1B2KO
Mice
To support the observations that younger obB1B2KO mice
release higher amounts of insulin after glucose stimulation, we
measured circulating insulin in blood samples taken from fasted
and fed 3-month-old mice. The results obtained did not show any
difference between obWT and obB1B2KO mice (figure 5A). On
the other hand, insulin is a quite unstable molecule with a short
half life time. Therefore, the insulin C-peptide, which is cleaved
from proinsulin and released together with insulin in comparable
amounts from pancreatic beta-cells, is considered a better
measurement of insulin secretion in vivo [17]. The analysis of
serum samples revealed that fed obB1B2KO mice have doubled
C-peptide levels compared to their controls (figure 5B). This
suggests that insulin secretion is indeed increased in younger
obB1B2KO mice, but due to increased insulin clearance,
measured insulin levels are comparable to those of obWT at the
moment when the samples were collected.
We also measure the serum insulin and C-peptide concentra-
tions after anesthesia and after 1 g glucose i.p. injections in 6-
month-old mice. The obB1B2KO mice presented again, under
these new conditions, higher glycemia (figure 5C and D). The
same tendency was observed for serum insulin (figure 5E and F)
and for serum C-peptide (figure 5G and H) levels.
The Kallikrein-kinin System has a Protective Effect
Against NAFLD in Obese Mice
Due to the close link between NASH, obesity and T2DM, we
next investigated the morphology of the liver of obB1B2KO and
obWT mice. The obB1B2KO mice presented a significant
increase in liver mass compared to obWT animals (figure 6A
and B). The histopathological analysis showed a higher prevalence
of macrovesicular lesions in the liver of obB1B2KO mice
accompanied by a trend towards greater extent of areas of
steatosis (figure 6C to F). We however did not find significant
differences in deposition of collagen when analyzed by Masson’s
trichrome staining (figure 6D). The steatotic lesions developed
despite animals having similar plasma triglycerides and cholesterol
levels (figure 6G and H). Additionally, we observed an increase in
plasma concentrations of the aspartate aminotransferase and
alanine aminotransferase transaminases, which are bona fide
markers of liver function (figure 6I and J). These results indicate
that obese mice lacking kinin receptor are more prone to liver
injury.
Six-month-old obB1B2KO Mice have Higher
Gluconeogenesis and Increased Expression of
Gluconeogenesis Regulatory Enzymes in the Liver
The liver is the main source of glucose during fasting states and
impaired hepatic gluconeogenesis is a primary cause of T2DM [5].
To test glucose production, the animals were subjected to 24 hours
fasting and received an intraperitoneal injection of pyruvate. The
Figure 3. Western blot analysis of liver and muscle insulin receptor phosphorylation. Graphic and representative images of western blot
analysis of phosphorylated insulin receptors (p-IR)/total insulin receptors (t-IR) of protein extracts from A) liver and B) muscle, after
immunoprecipitation. Mice were starved for 12 hours overnight. After anesthesia with sodium thiopental, the abdomen was opened and insulin
(+) or saline (2) were injected in the cava vein. Liver and muscle samples were collected 2 or 5 minutes after the injections. The data are presented as
means 6 SEM. *, p,0.05; **, p,0.01.
doi:10.1371/journal.pone.0040573.g003
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Figure 4. Islets from obB1B2KO mice release more insulin. Insulin secretion and analysis of pancreatic islets from 3-month-old (A and C) and
6-month-old mice (B and D) when exposed to medium containing various concentrations of glucose (EC50 = 16.97+/20.352 and 11.30+/20.196; for
3-month-old obWT and obB1B2KO respectively (average +/2 SD) and 8.41+/20.217 and 6.29+/20.651 for 6-month-old mice); E and G) Dynamic
analysis of insulin secretion from islets of 3-month-old mice; F and H to K) Dynamic analyzes of insulin secretion from islets from 6-month-old mice. K
Effect of Kinin Receptor Deficiency in ob/ob Mice
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blood glucose concentration was measured at time points 0, 30, 45
and 60 minutes after the injection. The obB1B2KO animals
showed higher production of glucose after administration of
pyruvate when compared to obWT mice (figure 7A).
The liver was further examined for expression of regulatory
enzymes involved in the activation of gluconeogenesis: glucose-6-
phosphatase (G6Pase), phosphoenolpyruvate carboxykinase
(PEPCK) and fructose-1,6-bisphosphatase 1 (FbP1). Furthermore,
the expression of forkhead box protein O1 (FoxO1), which
regulates the expression of G6Pase and PEPCK, and peroxisome
proliferator-activated receptor gamma coactivator 1-alpha (PGC-
1a) were analyzed. All these factors showed increased mRNA
expression in the liver of obB1B2KO compared to obWT mice,
consistent with increased gluconeogenesis.
No significant differences were observed in FoxO3 and FoxO4
expression, as well as in regards to sterol regulatory element-
binding protein 1 (SREB). Additionally, we observed a trend to
increased expression of hepatocyte nuclear factor 4 alpha (HNF4)
and a dramatic decrease of 25-hydroxycholesterol 7-alpha-
hydroxylase (CYP7b1) expression, which is negatively regulated
by FoxO1 [18].
Discussion
In the present study we generated an animal model deficient in
leptin and both B1 and B2 kinin receptors to study the influence of
the KKS on the pathophisiology of obesity and T2DM. These
animals show an age dependent increase in glycemia, insulin
resistance, as well as steatosis and hepatomegaly.
These results are consistent with previous reports describing that
BK can promote glucose uptake and insulin sensitivity in muscles
and adipose tissues in vitro and in isolated systems [19,20,21].
These reports show increased GLUT4 translocation in these
tissues when stimulated with BK. However, in the present work we
show the influence of the KKS in liver metabolism, an organ that
is not dependent on GLUT4. Moreover, the fact that younger
animals did not show any differences in terms of glucose tolerance
led us to hypothesize that other pathways that control glucose
homeostasis might have also been affected in obB1B2KO mice.
One obvious hypothesis was insulin secretion in pancreas. At 3
months of age, obB1B2KO mice have similar glycemia and
glucose tolerance as the controls. However, increased hepatic
insulin resistance was observed in 3 month-old obB1B2KO mice
while the islets from obB1B2KO at the same age were able to
secrete more insulin, overlapping any possible difficulty in glucose
uptake caused by the KO of the kinin receptors. Nevertheless, 3-
month-old obB1B2KO mice show similar insulin tolerance when
compared to obWT mice, suggesting that differences in insulin
resistance between these animals are age dependent and do not
occur in younger mice. Thus, a defect in insulin clearance may be
the most obvious explanation since insulin secretion is increased in
isolated pancreatic islets from obB1B2KO mice whereas insulin
levels and tolerance as well as fasting glucose levels and tolerance
are similar. Although we cannot confirm this hypothesis, it is
further corroborated by the observation of higher insulin C-
peptide levels in 3 months old obB1B2KO mice (figure 5).
Hepatic steatosis is associated with obesity and obesity is
associated with a reduced insulin clearance [22]. In this work we
compared absence and presence of the two kinin receptors B1 and
B2 on a leptin deficient background, showing that the degree of
adiposity (figure 1), as well as the lipid profile (figure 6) are not
influenced by these receptors in this model. While a large body of
literature is available about insulin secretion under different
pathophysiological conditions, relatively little is known about
insulin clearance [22]. The liver as the main site of insulin
clearance, removes approximately 50% during the first portal
passage [23,24]. Our results show that the islets of obB1B2KO
mice have an increased capacity to produce insulin when
stimulated with high glucose concentrations, mainly at 3 months
of age. At the same time, the western blot analysis shows an
increase of hepatic insulin resistance and normal insulin sensitivity
in skeletal muscle. In summary, 3-month-old obB1B2KO mice
present increased insulin production (figure 5 and 6), increased
hepatic insulin resistance while having normal insulin sensitivity in
muscle (figure 3). Together these results provide the basis of a new
explanation for the normal glucose uptake in animals of this age
(figure 2). Following this hypothesis, after glucose injection, the
more responsive islets of obB1B2KO mice are able to deliver
higher amounts of insulin, which is then not completely degraded
after portal passage. The remaining insulin reaches the receptors
in the muscle, which are equally sensitive to insulin in obB1B2KO
and in obWT muscle at this age.
With age, in ob/ob mice, hyperglycemia is reduced by reasons
that have not been completely elucidated [16,25,26]. Our data
show that the improvement in glucose homeostasis in 6-month-old
obWT mice is accompanied by increased insulin secretion
capacity of the pancreatic islets. This is consistent with observa-
tions that the islets from obese mice are bigger at this age when
compared to islets from younger obese mice [25]. ObB1B2KO
mice can compensate the absence of kinin receptors through
higher capacity to secrete insulin at 3 months of age, but show
higher hyperglycemia at 6 months of age. This is due to the
inability of their islets to further increase insulin secretion to
compensate increased insulin resistance and increased hepatic
glucose production. These results suggest that the dysregulation of
the KKS could be associated with a higher risk of developing
T2DM as aging advances. Concerning the increase in prevalence
of T2DM in children and adolescents [27,28], it is important to
note that the risk of developing T2DM as well as its complications
significantly increase with age [29]. Further studies will be
necessary to analyze whether the KKS of patients with T2DM
has its function modified in comparison to healthy subjects. The
importance of the KKS to T2DM suggested by our results is
reinforced by the fact that patients treated with angiotensin I-
converting enzyme (an enzyme able to degrade kinins) inhibitors
display protection against complications from this disease
[30,31,32].
Our results show that in addition to increased insulin resistance
in peripheral tissues, augmented endogenous glucose production is
also important to generate the higher hyperglycemia in 6-month-
old obB1B2KO mice. This conclusion is supported by higher
glucose production in the pyruvate challenge test and the
increased hepatic mRNA expression of FoxO1, PEPCK, G6Pase,
FbP1 and PGC-1a, whose protein products are linked with the
activation of gluconeogenesis [33,34]. Therefore, since insulin is
known to decrease the expression of these genes in liver [34], these
data also suggest that the absence of the kinin receptor can
decrease hepatic insulin sensitivity in these animals. Hepatic
endogenous glucose production is the main cause of hyperglyce-
mia in human T2DM patients [5]. Thus it is tempting to speculate
and I) Analysis showing extended recovery time of basal insulin secretion levels from islets of obB1B2KO mice. Data present means6 SEM. *, p,0.05;
n = 865 islets for static analyzes and n = 4650 islets for dynamic analyzes.
doi:10.1371/journal.pone.0040573.g004
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that the KKS may influence hepatic endogenous glucose
production and the pathophysiology of T2DM in humans. In this
case, the difficulty of achieving glycemic control in some patients
may be related to different activity of the KKS in these patients.
ObB1B2KO mice also present increased hepatomegaly with
more severe steatosis and augmented plasma concentration of
ALT and AST in comparison to obWT mice. These changes
appear although they display no differences in serum cholesterol
and triglycerides levels. The worsening of steatosis in obB1B2KO
mice suggests that KKS has a protective effect on the liver of these
obese animals. The effects of double deletion of the B1 and B2
kinin receptors are related to enhanced renal injury in the Akita
mice model of diabetes [35]. This observation fits well with
findings of the present work, since we observed that the absence of
kinin receptors also suggest a protective role of the KKS in these
tissues. On the other hand, we have previously published that the
absence of the B1 receptor is beneficial in lean mice lowering
fasting glucose [15] and increasing the resistance to obesity
induced by high fat diet [14]. It is important to note that resistance
to obesity in these animals is dependent on increased leptin
Figure 5. Three-month-old obB1B2KOmice have 2-fold more C-peptide levels. A) Serum insulin levels of starved and random fed mice at 3
months of age. B) Serum insulin C-peptide concentrations. C) Serum glucose after anesthesia with avertin and i.p. injection of 1 g glucose/kg body
weight. D) Area under the curves of ‘‘C’’. E and F) Serum insulin and, G and H) serum C-peptide from the same experiment in ‘‘C’’. The data are
presented as means 6 SEM. *, p,0.05; **, p,0.01; ***, p,0.001, n = 8 for ‘‘A’’ and ‘‘B’’, n = 4 for ‘‘C’’ to ‘‘H’’.
doi:10.1371/journal.pone.0040573.g005
Figure 6. KKS protects the liver against steatosis in obese mice. A) Representative picture of the sizes of livers from 6-month-old mice; B)
Averages of liver relative mass from 6-month-old mice; C) Representative picture comparing hematoxylin and eosin stained liver sections; D)
Representative picture comparing Masson’s trichrome protocol; E) Percentage of the predominant type of non-alcoholic hepatic steatosis from
histological analysis; F) Percentage of non-alcoholic hepatic steatosis levels from histological liver analysis; G and H) Serum lipid profile; I and J)
Hepatic function analysis demonstrated by plasma transaminases measurements, aspartate aminotransferase (AST) and alanine aminotransferase
(ALT). The data are presented as the means 6 SEM. t student: *, p,0.05; **, p,0.01; Analysis of Contingency Table: # #, p,0.01; n = 8.
doi:10.1371/journal.pone.0040573.g006
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sensitivity and is therefore absent in mice additionally lacking
leptin [14]. It is also known that in the absence of one of the kinin
receptors, the expression of the other receptor increases in several
tissues, a fact that can be related to changes in the phenotype of
these models [11,36].
The obese ob/ob mice have been used as a model for hepatic
steatosis, although they normally present no inflammation. The
mechanism involved in the development of steatosis in these
animals is related to higher delivery of fatty acids to the liver and
enhanced hepatic lipogenesis [37]. However, several studies show
that leptin is essential for the deposition of hepatic fibrosis. Thus,
ob/ob mice do not develop spontaneous or diet induced fibrosis
[38,39,40,41]. Previous work shows that bradykinin has a
protective effect against liver damage and fibrosis induced in rats
by treatment with carbon tetrachloride [42]. In this work, we
provide evidences that the KKS is involved with hepatic
metabolism, but we cannot show development of fibrosis due to
the absence of leptin in our models.
In conclusion, we demonstrate that the KKS plays an important
role in the pathophysiology of obesity and T2DM. Even though
several reports describe the importance of the KKS in the
pathophysiology of heart, kidney and retina diseases [12,43,44],
little was known about the effect of the KKS upon the
etiopathogenesis of obesity and T2DM, in particular in terms of
liver function. This could pave the way for interventions that
promote glycemic control in obese and T2DM patients.
Materials and Methods
Animals
Lepob/Lepob and Bdkrb1.b2tm/Bdkrb1.b2tm mice, referred in
this work as obWT and B1B22/2 respectively, all on C57BL/6j
genetic background, were obtained from the Centre for the
Development of Experimental Animal Models (CEDEME),
Federal University of Sa˜o Paulo (UNIFESP). The infertility of
obWT male mice was reverted with white adipose tissue
transplantation technique [45]. These males were used to mate
B1B22/2 females to generate the Lepob.Bdkrb1.b2tm/Le-
pob.Bdkrb1.b2tm, referred below as obB1B2KO. Mice received
commercial rodent food and neutral pH water ad libitum (Nuvi
Lab, Nuvital Parana´, Brazil) and were maintained under a 12-h
light/12-h dark cycle under constant room temperature (2261uC)
and humidity (6063%) conditions. The experiments were carried
out with females. All procedures complied with the standards for
the care and use of animals as stated in the guide for the care and
use of laboratory animals (UNIFESP).
Glycemic Analysis
Glycemic tests were performed in 3- and 6-month-old mice.
The glucose tolerance test (GTT) and insulin tolerance test (ITT)
were carried out in animals fasted for 12 hours. To avoid stress
there was an interval of 7 days between tests. Glycemia was
measured using a glucometer (Accu-Chek Advantage) measuring
blood drops obtained from the tail vein. For GTT 1 g glucose per
kg of body weight (BW) and for ITT 1 IU of insulin per kg BW
was injected intraperitoneally.
To analyze insulin and C-peptide levels in serum after glucose
load, 12 hours starved 6-month-old mice were anesthetized with
250 mg/kg Avertin (tribromoethanol). The animals were placed
on a thermal plate to keep body temperature around 37uC. After
15 minutes of stabilization, we measured glycemia by a drop of
blood from the tail and collected blood samples from the
retroocular plexus. These procedures were repeated sequentially
after 3, 6, 10, 15 and 30 minutes and the serum was separated by
centrifugation and frozen until use. Insulin and C-peptide levels
were measured using a Rat/Mouse Insulin ELISA Kit and Rat/
Mouse C-Peptide 2 ELISA Kit (Millipore Corporation, cat no
EZRMI-13K and EZRMCP2-21K, respectively).
Pyruvate Challenge
Mice deprived of food for 24 h were injected intraperitoneally
with sodium pyruvate (0.5 g/kg). Blood samples were collected
from the tail vein immediately before and at various time points
(0–60 min) after the pyruvate load.
Tissue Extraction and Immunoprecipitation
Mice were anesthetized with sodium thiopental and analyzed
10–15 min later. As soon as anesthesia was assured by the loss of
Figure 7. Increased gluconeogenesis and hepatic expression of FoxO1, PGC-1a and gluconeogenesis regulatory enzymes. The
experiments were performed in 6-month-old mice. A) Pyruvate challenge proceeded by intraperitoneal injection of 0.5 g/kg pyruvate; B) Quantitative
real time PCR: The results are expressed as changes relative to the control obWT group. Forkhead box protein O1, 03 and 04 (FoxO1, O3 and O4),
phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-phosphatase (G6Pase), glucokinase (GCK), fructose-1,6-bisphosphatase 1 (FbP1), hepatocyte
nuclear factor 4 alpha (Hnf4), 25-hydroxycholesterol 7-alpha-hydroxylase (CYP), carnitine palmitoyltransferase-1 (CPT1), Sterol regulatory element-
binding protein 1 (SREB), peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1a). Data are presented as the means 6 SEM.
Student’s t-test: *, p,0.05; **, p,0.01; ***, p,0.001; n = 5.
doi:10.1371/journal.pone.0040573.g007
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pedal and corneal reflexes, the abdominal cavity was opened, the
portal vein exposed and 0.2 mL normal saline with or without
insulin (2 mg) injected. Two minutes after the insulin injection, a
fragment from the liver was removed, and 3 minutes later, muscle
tissue was collected, minced coarsely, and homogenized immedi-
ately in extraction buffer containing protease and phosphatase
inhibitors, as described elsewhere [46]. Extracts were then
centrifuged at 15,000 rpm and 4uC for 40 min to remove
insoluble material, and the supernatants were immunoprecipitated
with anti-IR (sc-711, rabbit polyclonal, Santa Cruz Biotechnology)
and protein A-Sepharose 6 MB (Pharmacia, Uppsala, Sweden).
Protein Analysis by Immunoblotting
The precipitated proteins were treated with Laemmli sample
buffer [47] containing 100 mM dithiothreitol and heated in a
boiling water bath for 5 min, after which they were subjected to
SDS-PAGE in a Bio-Rad miniature slab gel apparatus (Mini-
Protean). Electrotransfer of proteins from the gel to nitrocellulose
membrane was performed for 120 min at 120 V in a Bio-Rad
Mini-Protean transfer apparatus. Nonspecific protein binding to
the nitrocellulose was reduced by preincubating the filter for 2 h in
blocking buffer (5% nonfat dry milk, 10 mm Tris, 150 mm NaCl,
0.02% Tween 20). The nitrocellulose blot was incubated with anti-
phosphotyrosine antibody (sc-508, mouse monoclonal antibody,
Santa Cruz Biotechnology) overnight at 4uC and then incubated
with 125I-labeled protein A. The results were visualized by
autoradiography on a preflashed Kodak XAR film. Band
intensities were quantified by optical densitometry (Hoefer
Scientific Instruments, San Francisco, CA, USA; model GS300).
Morphometric Analysis
To determine the growth curve and the obesity development,
body weight was measured weekly until the mice reached the age
of 26 weeks. Thirty-week-old mice were sacrificed and their body
weights as well as their organ weights were measured. Liver pieces
were saved in buffered formalin or frozen in liquid nitrogen for
further analysis. For histopathologic analysis, liver sections were
stained with hematoxylin & eosin and Masson’s trichrome
protocol. To analyze the steatosis, a pathologist classified the
slides in a blind analysis in two classes of steatosis types
(predominantly microvesicular or macrovesicular lesions) and in
4 classes for the levels of steatosis (0 to 25%, 26 to 50%, 51 to 75%
and 76 to 100% of areas with steatotic lesions).
Insulin Secretion in Isolated Islets
Pancreatic islets were isolated by collagenase digestion as
described previously [48]. Briefly, the mice were sacrificed by
cervical dislocation, and collagenase was administered into the
pancreas by retrograde injection via the pancreatic duct. After 15–
20 minutes of incubation at 37uC, the islet suspension was washed
4 times with Hank’s balanced salt solution at 4uC, before being
manually collected. For static incubation, groups of four freshly
isolated islets were initially pre-incubated for 45min at 37 uC in
Krebs-Ringer bicarbonate buffer with the following composition
(in mmol/l): NaCl, 115; KCl, 5; CaCl2, 2.56; MgCl2, 1; NaHCO3,
24; and glucose, 5.6; supplemented with BSA (0.3% w:v) and
equilibrated with a mixture of 95% O2:5% CO2, pH 7.4. The
solution was then replaced, and the islets incubated for 90 min
under the experimental conditions (2.8, 5.6, 11.2, 16.8, 22.4, 28.0
or 33,6 mmol/l glucose). For dynamic incubations, groups of 50
freshly isolated islets were placed on Millipore SW 1300 filters
(8.0 mm pore) and perifused with Krebs-Ringer bicarbonate buffer
at a flow rate of 1 mL/min for 30 min in the presence of
2.8 mmol/L glucose (basal conditions). Subsequently, the islets
were perifused with 11.1 mmol/L or 22.2 mmol/L of glucose.
Perifusion solutions were gassed with 95% O2/5% CO2 and
maintained at 37uC. Samples of perifused solution were collected
each 1 or 2 min. Insulin release was measured by radioimmuno-
assay.
Body Composition
Total body fat was estimated in 25-week-old mice by dual-
energy X-ray absorptiometry using a Hologic QDR 4500 scanner
(Hologic, Waltham, MA) as described previously [49].
Gene Expression Analysis
Quantitative real-time PCR (qRT-PCR) was used to determine
expression levels of distinct liver mRNAs. Briefly, tissue pieces
from 12 hours fasted mice were removed, snap frozen in liquid
nitrogen, and stored at 280uC until use. Samples were homog-
enized and total RNA was isolated using a NucleoSpin RNA II
purification kit (Macherey-Nagel) and then stored at 280uC until
use. The RNA integrity was assessed by electrophoresis on agarose
gels. cDNA was synthesized from 1 mg of total RNA with Moloney
murine leukemia virus reverse transcriptase (Promega) using
random hexamer nucleotides. Standard curves for the primers
were made to determine the amplification efficiencies of target and
reference genes. Quantitative PCR was performed on an ABI
Prism 7900 sequence detection system with 100 nM primers and
5 ng of cDNA. Target mRNA expression was normalized to b-
actin expression and expressed as a relative value using the
comparative threshold cycle (Ct) method (22DDCt) according to the
manufacturer’s instructions. Expression levels from genes of
interest were normalized to obWT control mice and presented
as fold change. The primers sequences used are available in table
S2.
Statistical Analysis
All values were expressed as means + SEM. Statistical analyses
were carried out using the two-tailed Student’s unpaired t-test to
compare two independent groups or ANOVA followed by
Bonferroni’s test to compare more than two groups. Contingency
Table was used to analyze value distribution. Significance was
rejected at P.0.05.
Supporting Information
Table S1 Mass of organs and tissues.
(DOCX)
Table S2 Primers sequences for qPCR.
(DOCX)
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